Robert Lutz - Chief Financial & Business Officer and Principal Accounting Officer at iBio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial & Business Officer and Principal Accounting Officer
Stock Symbol
IBIO on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Lutz since 7/7/2023

Holdings reported by Robert Lutz for iBio, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 102,165 $27.1 K $0.27 Nov 11, 2022 Direct
Stock Option (right to buy) 400,000 Aug 29, 2022 Direct Common Stock

Transactions reported by Robert Lutz for iBio, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership